Home/Filings/4/0000950170-24-130754
4//SEC Filing

Spoor Johan M. 4

Accession 0000950170-24-130754

CIK 0000728387other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 7:00 AM ET

Size

33.2 KB

Accession

0000950170-24-130754

Insider Transaction Report

Form 4
Period: 2024-11-25
Spoor Johan M.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2024-11-25$3.80/sh+5,400$20,5205,400 total(indirect: By IRA)
  • Purchase

    Common Stock

    2024-11-25$3.80/sh+6,600$25,08066,600 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2024-11-25$3.78/sh+14,500$54,868152,072 total
Holdings
  • Common Stock

    (indirect: By Children)
    10,000
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.645 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transactions described in this footnote.

Issuer

Perspective Therapeutics, Inc.

CIK 0000728387

Entity typeother

Related Parties

1
  • filerCIK 0001535289

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 7:00 AM ET
Size
33.2 KB